Halozyme
HALO
193 hedge funds and large institutions have $2.07B invested in Halozyme in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 70 increasing their positions, 74 reducing their positions, and 31 closing their positions.
93% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $5.36M
0.71% less ownership
Funds ownership: 86% → 85.29% (-0.71%)
5% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 74
8% less funds holding
Funds holding: 209 → 193 (-16)
14% less capital invested
Capital invested by funds: $2.42B → $2.07B (-$350M)
48% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 31
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$43.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
| 3 |
BlackRock
New York
|
+$12.5M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$10.8M |
| 5 |
Axa
Paris,
France
|
+$7.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$24.4M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$17.9M |
| 3 |
First Eagle Investment Management
New York
|
-$16.6M |
| 4 |
Two Sigma Investments
New York
|
-$13.2M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.44M |
HALO Hedge Fund Activity: Q2 2018 in Review
193 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2018, worth a combined $2.07B — down 14% from $2.42B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of HALO and 16 opened new positions — a net loss of 15 holders — while 74 trimmed existing stakes and 70 added.
The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $43.8M. The largest seller was Millennium Management, cutting an estimated $24.4M.
- 193 institutional investors held Halozyme (HALO) as of Q2 2018, down from 209 in Q1 2018.
- Funds reported $2.07B of Halozyme stock for Q2 2018, down 14% quarter-over-quarter.
- 16 funds opened new Halozyme positions in Q2 2018 and 31 closed out, a net change of -15 holders.
- The largest Halozyme buyer in Q2 2018 was Thrivent Financial for Lutherans, an estimated $43.8M added.
- The largest Halozyme seller in Q2 2018 was Millennium Management, an estimated $24.4M sold.
Based on aggregated 13F filings for Q2 2018.